Product Reports Resources Pricing Login Book a demo
Investor profile

Sofinnova Partners

Venture Capital · Founded 1972 · Paris, France

Leading European venture capital firm specialized in Life Sciences, often lead role in round A financings

200 portfolio companies Venture Capital · $10B invested · 371 investments · Investor rank #275 · Last investment 8/2026
Portfolio companies 200 ↑ 33% 5y
Decacorns 6
Thoroughbreds 12 ↑ 13% 5y
01 · Biggest holdings

Sofinnova Partners’ biggest current holdings.

The most valuable companies Sofinnova Partners still holds — unicorns and thoroughbreds it has backed, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead.

#CompanyEst. stakeValuationEst. value
  1. 1 OdooUnicorn · Marketing · Belgium $7.7B
  2. 2 F2GHealth · UK $500M

Estimated value = Sofinnova Partners’ disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →

02 · Exits

Sofinnova Partners’ biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Sofinnova Partners’ transaction record.

Viatris
IPO · 1978
Now $31BHealth
IPO · 2013
Entered Series ANow $30BHealth
$373M IPO · 2015
Entered Series ANow $17BHealth
$457M IPO · 2019
Entered Series ANow $13BHealth
Abivax
$226M IPO · 2015
Now $10BHealth
$163M IPO · 2017
Now $10BHealth
IPO · 2016
Entered Series B+Now $6.2BHealth
Shire
IPO · 2003
Now $5.9BHealth
$691M IPO · 2017
Entered Series B+Now $5.3BHealth
IPO · 2007
Entered Series ANow $4.8BHealth
Hemab Therapeutics
$841M IPO · 2026
Entered Series B+Now $2.2BHealth
$2.1B acquisition · 2020
Entered SeedHealth
03 · Portfolio analysis

Where Sofinnova Partners’ portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 200 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. France77
  2. USA60
  3. UK28
  4. Italy13
  5. Switzerland12
  6. Germany6
  7. Denmark5
  8. Netherlands5
  9. Belgium4
  10. Ireland4
  11. Israel3
  12. Sweden3
By sectorCount
  1. Health161
  2. Enterprise Software14
  3. Food11
  4. Energy8
  5. Chemicals6
  6. Security6
  7. Telecom6
  8. Marketing5
  9. Semiconductors5
  10. Fintech3
  11. Robotics3
  12. Wellness Beauty3
By stage enteredCount
  1. Series A112
  2. Series B+43
  3. Seed36
By growth stageCount
  1. Breakout Stage112
  2. Late Growth70
  3. Early Growth41
  4. Mature6
04 · Portfolio market map

Inside Sofinnova Partners’ portfolio.

The 60 highest-funded portfolio companies, of 200 tracked.

RefleXion Medical
Health
$550M
CellCentric
Health
$880M
Artios Pharma
Health
$765M
F2G
Health
$500M
Hemab Therapeutics
Health · Unicorn
$2.2B
DNA Script
Health
$825M
Aledia
Semiconductors
$650M
Amolyt Pharma
Health
$800M
Chroma Medicine
Health
$540M
Galvanize Therapeutics
Health
$400M
Tissium
Health
$275M
AAVantgarde Bio
Health
$564M
HotSpot Therapeutics
Health
$400M
CinCor Pharma
Health · Unicorn
$1.8B
Mediar Therapeutics
Health
$425M
DBV Technologies
Health
$644M
MISSION Therapeutics
Health
$396M
Avantium
Chemicals
$304M
GlycoEra
Health
$520M
Checkmate Pharmaceuticals
Health
$340M
Amplyx Pharmaceuticals
Health
$212M
Noema Pharma
Health
$472M
Apellis Pharmaceuticals
Health · Unicorn
$5.3B
Purespring Therapeutics
Health
$422M
Bionyra Pharma
Health
$660M
Myricx Bio
Health · Unicorn
$1.1B
Merus
Health · Unicorn
$6.2B
Chiasma
Health
$330M
Inside Secure
Security
$286M
Crescendo Biologics (Formerly Translocus)
Health
$314M
Tenpoint Therapeutics
Health
$340M
Shockwave Medical
Health · Decacorn
$13B
Redona Therapeutics
Health
$60M
Neurent Medical
Health
$80M
Entasis Therapeutics
Health
$196M
Inspirna
Health
$200M
Sensorion
Health
$113M
Asceneuron
Health
$400M
Crocus Technology
Semiconductors
$420M
T-Therapeutics
Health
$295M
ABIONYX
Health
$92M
Hookipa Pharma
Health
Inotrem
Health
$32M
ENYO Pharma
Health
$220M
Arzeda
Health
$152M
IOmx Therapeutics AG
Health
$286M
CorWave
Health
$193M
Guavus
Enterprise Software
$215M
Novexel
Health
$260M
Iterum Therapeutics
Health
$528
TME Pharma
Health
$6.9M
SafeHeal
Health
$220M
Addex Therapeutics
Health
$5.0M
GenSight Biologics
Health
$34M
NanoPhoria
Health
$367M
Fovea Pharmaceuticals
Health
$120M
Blyk
Marketing
$75M
ObsEva
Health
$12
Verona Pharma
Health · Decacorn
$10B
Excelsior Sciences
Health
$280M
05 · Portfolio founders

Where Sofinnova Partners’ portfolio founders come from.

114 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. France36
  2. United States25
  3. United Kingdom17
  4. Denmark8
  5. Germany7
  6. Switzerland6
  7. Italy3
  8. Belgium2
  9. Netherlands2
  10. Australia1
UniversityCount
  1. École Polytechnique - IP Paris4
  2. Aarhus University3
  3. HEC Paris3
  4. INSEAD Business School3
  5. Massachusetts Institute of Technology3
  6. Sorbonne University3
  7. University of Cambridge3
  8. AgroParisTech - Paris-Saclay University2
  9. Ampleforth College2
  10. Durham University2
Previous companyCount
  1. Sanofi4
  2. Alphabet | Google3
  3. Pfizer3
  4. Sanofi Aventis3
  5. Stanford University3
  6. Archimej Technology2
  7. AstraZeneca2
  8. Bel Group2
  9. Bersin by Deloitte2
  10. CHUV - University Hospital Lausanne2